{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:11:41Z","timestamp":1789999901042,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"DOI":"10.1007\/s00775-025-02117-w","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:08:09Z","timestamp":1748999289000},"page":"411-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Organotin(IV) carboxylates\u2014derivatives of bexarotene: synthesis, characterization, anti\/prooxidant activity, and high cytotoxicity"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9820-0323","authenticated-orcid":false,"given":"D. A.","family":"Burmistrova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. P.","family":"Pomortseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. T.","family":"Berberova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. R.","family":"Almyasheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Kiskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. I.","family":"Poddel\u2019sky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Vashurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-2247","authenticated-orcid":false,"given":"I. V.","family":"Smolyaninov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2117_CR1","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos KD, Orvig C (2014) Metallodrugs in medicinal inorganic chemistry. Chem Rev 114:4540\u20134563. https:\/\/doi.org\/10.1021\/cr400460s","journal-title":"Chem Rev"},{"key":"2117_CR2","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1039\/D2CS00407K","volume":"51","author":"R Lengacher","year":"2022","unstructured":"Lengacher R, Marlin A, Smi\u0142owicz D, Boros E (2022) Medicinal inorganic chemistry\u2014challenges, opportunities and guidelines to develop the next generation of radioactive, photoactivated and active site inhibiting metal-based medicines. Chem Soc Rev 51:7715\u20137731. https:\/\/doi.org\/10.1039\/D2CS00407K","journal-title":"Chem Soc Rev"},{"key":"2117_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jinorgbio.2019.02.003","volume":"194","author":"CN Banti","year":"2019","unstructured":"Banti CN, Hadjikakou SK, Sismanoglu T, Hadjiliadis N (2019) Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives. J Inorg Biochem 194:114\u2013152. https:\/\/doi.org\/10.1016\/j.jinorgbio.2019.02.003","journal-title":"J Inorg Biochem"},{"key":"2117_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2020.119464","volume":"505","author":"A Khana","year":"2020","unstructured":"Khana A, Parveena S, Khalida A, Shafia S (2020) Recent advancements in the anticancer potentials of phenylorganotin(IV) complexes. Inorg Chim Acta 505:119464. https:\/\/doi.org\/10.1016\/j.ica.2020.119464","journal-title":"Inorg Chim Acta"},{"key":"2117_CR5","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.ejmech.2017.11.001","volume":"143","author":"M Sirajuddin","year":"2018","unstructured":"Sirajuddin M, McKee V, Tariq M, Ali S (2018) Newly designed organotin(IV) carboxylates with peptide linkage: synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations. Eur J Med Chem 143:1903\u20131918. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.001","journal-title":"Eur J Med Chem"},{"issue":"11","key":"2117_CR6","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1021\/acs.inorgchem.8b00413","volume":"57","author":"L Hu","year":"2018","unstructured":"Hu L, Wang H, Xia T, Fang B, Shen Y, Zhang Q, Tian X, Zhou H, Wu J, Tian Y (2018) Two-photon-active organotin(IV) complexes for antibacterial function and superresolution bacteria imaging. Inorg Chem 57(11):6340\u20136348. https:\/\/doi.org\/10.1021\/acs.inorgchem.8b00413","journal-title":"Inorg Chem"},{"key":"2117_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2023.121695","volume":"557","author":"M Dahmani","year":"2023","unstructured":"Dahmani M, Titi A, Et-Touhami A, Yahyi A, Touzani R, Siaj M, Zarrouk A, Al Obaid AA, Saadi M, El Ammari L, Warad I (2023) Novel 3-(2-thienyl) acrylic acid bridge di-triphenyltin(IV) [(Ph)3SnCl)2COO]-[Et3NH]+, [(Ph)3SnCl2)]-[Et3NH]+ complex: XRD\/HSA-interactions, physicochemical, thermal and POM\/antifungal evaluation. Inorg Chim Acta 557:121695. https:\/\/doi.org\/10.1016\/j.ica.2023.121695","journal-title":"Inorg Chim Acta"},{"key":"2117_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2021.121913","volume":"948","author":"M Dahmani","year":"2021","unstructured":"Dahmani M, Harit T, Et-Touhami A, Yahyi A, Eddike D, Tillard M, Benabbes R (2021) Two novel macrocyclic organotin (IV) carboxylates based on bipyrazoledicarboxylic acid derivatives: syntheses, crystal structures and antifungal activities. J Organomet Chem 948:121913. https:\/\/doi.org\/10.1016\/j.jorganchem.2021.121913","journal-title":"J Organomet Chem"},{"key":"2117_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2021.122191","volume":"960","author":"TA Antonenko","year":"2022","unstructured":"Antonenko TA, Gracheva YuA, Shpakovsky DB, Vorobyev MA, Tafeenko VA, Mazur D, Milaeva ER (2022) Cytotoxic activity of organotin compounds containing non-steroidal anti-inflammatory drugs. J Organomet Chem 960:122191. https:\/\/doi.org\/10.1016\/j.jorganchem.2021.122191","journal-title":"J Organomet Chem"},{"key":"2117_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2019.121089","volume":"909","author":"TA Antonenko","year":"2020","unstructured":"Antonenko TA, Shpakovsky DB, Berseneva DA, Gracheva YuA, Dubova LG, Shevtsov PN, Redkozubova OM, Shevtsova EF, Tafeenko VA, Aslanov LA, Milaeva ER (2020) Cytotoxic activity of organotin carboxylates based on synthetic phenolic antioxidants and polycyclic bile acids. J Organomet Chem 909:121089. https:\/\/doi.org\/10.1016\/j.jorganchem.2019.121089","journal-title":"J Organomet Chem"},{"key":"2117_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2024.122388","volume":"574","author":"E Nikitin","year":"2025","unstructured":"Nikitin E, Fedorov S, Gracheva Y, Lyssenko K, Semykin A, Oprunenko Yu, Sobolev N, Mazur D, Dubova L, Shevtsova E, Milaeva E (2025) Organotin carboxylates with bulky substituents. Synthesis, structure, cytotoxicity and antioxidant activity. Inorg Chim Acta 574:122388. https:\/\/doi.org\/10.1016\/j.ica.2024.122388","journal-title":"Inorg Chim Acta"},{"key":"2117_CR12","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1039\/C5DT00862J","volume":"44","author":"F Ali Shah","year":"2015","unstructured":"Ali Shah F, Sabir S, Fatima K, Ali S, Qadri I, Rizzoli C (2015) Organotin(IV) based anti-HCV drugs: synthesis, characterization and biochemical activity. Dalton Trans 44:10467\u201310478. https:\/\/doi.org\/10.1039\/C5DT00862J","journal-title":"Dalton Trans"},{"key":"2117_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2024.112609","volume":"258","author":"J He","year":"2024","unstructured":"He J, Wang Y, Su C, Hu Y, Hu W, Hu L, Wang H (2024) Synthesis and anti-tumor activities of three newly designed organotin(IV) carboxylates complexes. J Inorg Biochem 258:112609. https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112609","journal-title":"J Inorg Biochem"},{"key":"2117_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2021.108798","volume":"167","author":"MEK Stathopoulou","year":"2021","unstructured":"Stathopoulou MEK, Zoupanou N, Banti CN, Douvalis AP, Papachristodoulou C, Marousis KD, Spyroulias GA, Mavromoustakos T, Hadjikakou SK (2021) Organotin derivatives of cholic acid induce apoptosis into breast cancer cells and interfere with mitochondrion; Synthesis, characterization and biological evaluation. Steroids 167:108798. https:\/\/doi.org\/10.1016\/j.steroids.2021.108798","journal-title":"Steroids"},{"key":"2117_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2023.122997","volume":"1006","author":"W Tian","year":"2024","unstructured":"Tian W, Wang J, Zhong W, Huang H, Ji M, Yang T, Lin S, Chen S, Yang P (2024) Synthesis, crystal structure and antitumor activity of trialkyltin (IV) 9,10-anthraquinone-2-carboxylate. J Organomet Chem 1006:122997. https:\/\/doi.org\/10.1016\/j.jorganchem.2023.122997","journal-title":"J Organomet Chem"},{"key":"2117_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2023.112399","volume":"250","author":"MP Kasalovi\u0107","year":"2024","unstructured":"Kasalovi\u0107 MP, Jela\u010da S, Maksimovi\u0107-Ivani\u0107 D, La\u0111arevi\u0107 J, Radovanovi\u0107 L, Bo\u017ei\u0107 B, Mijatovi\u0107 S, Panteli\u0107 ND, Kalu\u0111erovi GN (2024) Novel diphenyltin(IV) complexes with carboxylate N-functionalized 2-quinolone ligands: synthesis, characterization and in vitro anticancer studies. J Inorg Biochem 250:112399. https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112399","journal-title":"J Inorg Biochem"},{"key":"2117_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.100955","volume":"5","author":"R Joshi","year":"2023","unstructured":"Joshi R, Tomar N, Pokharia S, Joshi I (2023) Recent advancements in organotin(IV) complexes of drugs: synthesis, characterization, and application. Results Chem 5:100955. https:\/\/doi.org\/10.1016\/j.rechem.2023.100955","journal-title":"Results Chem"},{"key":"2117_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2017\/4736321","volume":"4736321","author":"Yu Nosova","year":"2017","unstructured":"Nosova Yu, Zenin I, Maximova V, Zhidkova E, Kirsanov K, Lesovaya E, Lobas A, Gorshkov M, Kovaleva O, Milaeva E, Galanski M, Keppler B, Nazarov A (2017) Influence of the number of axial bexarotene ligands on the cytotoxicity of Pt(IV) analogs of oxaliplatin. Bioinorg Chem Applications ID 4736321:6. https:\/\/doi.org\/10.1155\/2017\/4736321","journal-title":"Bioinorg Chem Applications ID"},{"key":"2117_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jorganchem.2017.03.031","volume":"839","author":"Y Nosova","year":"2017","unstructured":"Nosova Y, Karlov D, Pisarev S, Shutkov I, Palyulin V, Baquie M, Milaeva E, Dyson P, Nazarov A (2017) New highly cytotoxic organic and organometallic bexarotene derivatives. J Organomet Chem 839:91\u201397. https:\/\/doi.org\/10.1016\/j.jorganchem.2017.03.031","journal-title":"J Organomet Chem"},{"key":"2117_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2019.119010","volume":"495","author":"Y Okulova","year":"2019","unstructured":"Okulova Y, Zenina I, Shutkova I, Kirsanov K, Kovaleva O, Lesovaya E, Fetisov T, Milaeva E, Nazarov A (2019) Antiproliferative activity of Pt(IV) complexes with lonidamine and bexarotene ligands attached via succinate-ethylenediamine linker. Inorg Chim Acta 495:119010. https:\/\/doi.org\/10.1016\/j.ica.2019.119010","journal-title":"Inorg Chim Acta"},{"issue":"5","key":"2117_CR21","first-page":"1234","volume":"8","author":"C Zhang","year":"2002","unstructured":"Zhang C, Hazarika P, Ni X, Weidner DA, Duvic M (2002) Induction of apoptosis by Bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin Cancer Res 8(5):1234\u20131240","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/03639045.2016.1225752","volume":"43","author":"Y Wang","year":"2007","unstructured":"Wang Y, Rong J, Zhang J, Liu Y, Meng X, Guo H, Liu H, Chen L (2007) Morphology, in vivo distribution and antitumor activity of Bexarotene nanocrystals in lung cancer. Drug Dev Ind Pharm 43(1):132\u2013141. https:\/\/doi.org\/10.1080\/03639045.2016.1225752","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"2117_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/CAD.0b013e32836100d7","volume":"24","author":"SK Padda","year":"2013","unstructured":"Padda SK, Chhatwani L, Zhou L, Jacobs CD, Lopez-Anaya A, Wakelee HA (2013) Phase I and pharmacokinetic study of Bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report. Anticancer Drugs 24(7):731\u2013735. https:\/\/doi.org\/10.1097\/CAD.0b013e32836100d7","journal-title":"Anticancer Drugs"},{"key":"2117_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12885-018-4224-x","volume":"18","author":"X Ai","year":"2018","unstructured":"Ai X, Mao F, Shen S, Shentu Y, Wang J, Lu S (2018) Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2\/PPAR\u03b3\/PTEN\/mTOR signaling pathway. BMC Cancer 18:407. https:\/\/doi.org\/10.1186\/s12885-018-4224-x","journal-title":"BMC Cancer"},{"issue":"5","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1158\/1535-7163.MCT-05-0018","volume":"4","author":"WC Yen","year":"2005","unstructured":"Yen WC, Lamph WW (2005) The selective retinoid X receptor agonist Bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma. Mol Cancer Ther 4(5):824\u2013834. https:\/\/doi.org\/10.1158\/1535-7163.MCT-05-0018","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"2117_CR26","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/ijc.29542","volume":"137","author":"JN Kong","year":"2015","unstructured":"Kong JN, He Q, Wang G, Dasgupta S, Dinkins MB, Zhu G, Kim A, Spassieva S, Bieberich E (2015) Guggulsterone and Bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells. Int J Cancer 137(7):1610\u20131620. https:\/\/doi.org\/10.1002\/ijc.29542","journal-title":"Int J Cancer"},{"key":"2117_CR27","doi-asserted-by":"publisher","first-page":"1200947","DOI":"10.3389\/fmed.2023.1200947","volume":"10","author":"CL Moyer","year":"2023","unstructured":"Moyer CL, Brown PH (2023) Targeting nuclear hormone receptors for the prevention of breast cancer. Front Med 10:1200947. https:\/\/doi.org\/10.3389\/fmed.2023.1200947","journal-title":"Front Med"},{"key":"2117_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41598-021-04415-0","volume":"12","author":"LA Reich","year":"2022","unstructured":"Reich LA, Moerland JA, Leal AS, Zhang D, Carapellucci S, Lockwood B, Jurutka PW, Marshall PA, Wagner CE, Liby KT (2022) The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer. Sci Rep 12:293. https:\/\/doi.org\/10.1038\/s41598-021-04415-0","journal-title":"Sci Rep"},{"key":"2117_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173346","volume":"883","author":"NM Gretskaya","year":"2020","unstructured":"Gretskaya NM, Gamisonia AM, Dudina PV, Zakharov SS, Sherstyanykh G, Akasov R, Burov S, Serkov IV, Akimov MG, Bezuglov VV, Markvicheva E (2020) Novel bexarotene derivatives: synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models. Eur J Pharmacol 883:173346. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173346","journal-title":"Eur J Pharmacol"},{"key":"2117_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12032-021-01476-z","volume":"38","author":"C Hacioglu","year":"2021","unstructured":"Hacioglu C, Kar F, Kacar S, Sahinturk V, Kanbak G (2021) Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPAR\u03b3\/NF-\u03baB signaling pathway in C6 glioma cells. Med Oncol 38:31. https:\/\/doi.org\/10.1007\/s12032-021-01476-z","journal-title":"Med Oncol"},{"key":"2117_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.apha.2021.01.004","volume":"91","author":"AS Leal","year":"2021","unstructured":"Leal AS, Reich LA, Moerland JA, Zhang D, Liby KT (2021) Potential therapeutic uses of rexinoids. Adv Pharmacol 91:141\u2013183. https:\/\/doi.org\/10.1016\/bs.apha.2021.01.004","journal-title":"Adv Pharmacol"},{"issue":"2","key":"2117_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6089","volume":"35","author":"T Anasamy","year":"2020","unstructured":"Anasamy T, Chee CF, Wong YF, Heh CH, Kiew LV, Lee HB, Chung LY (2020) Triorganotin complexes in cancer chemotherapy: mechanistic insights and future perspectives. Appl Organomet Chem 35(2):e6089. https:\/\/doi.org\/10.1002\/aoc.6089","journal-title":"Appl Organomet Chem"},{"key":"2117_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.biochi.2020.09.027","volume":"179","author":"J Brtko","year":"2020","unstructured":"Brtko J, Dvorak Z (2020) Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action. Biochimie 179:157\u2013168. https:\/\/doi.org\/10.1016\/j.biochi.2020.09.027","journal-title":"Biochimie"},{"key":"2117_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S1600576714022985","volume":"48","author":"L Krause","year":"2015","unstructured":"Krause L, Herbst-Irmer R, Sheldrick GM, Stalke D (2015) Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination. J Appl Cryst 48:3\u201310. https:\/\/doi.org\/10.1107\/S1600576714022985","journal-title":"J Appl Cryst"},{"key":"2117_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","volume":"C71","author":"GM Sheldrick","year":"2015","unstructured":"Sheldrick GM (2015) Crystal structure refinement with SHELXL. Acta Cryst C71:3\u20138. https:\/\/doi.org\/10.1107\/S2053229614024218","journal-title":"Acta Cryst"},{"key":"2117_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1107\/S0021889808042726","volume":"42","author":"OV Dolomanov","year":"2009","unstructured":"Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, Puschmann H (2009) OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr 42:339\u2013341. https:\/\/doi.org\/10.1107\/S0021889808042726","journal-title":"J Appl Crystallogr"},{"key":"2117_CR37","unstructured":"Stroev EN, Makarova VG (1986) Praktikum po biologiheskoy khimii [Practical Work in Biological Chemistry]; Vushaya Shkola, Moscow (in Russian)"},{"key":"2117_CR38","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/poc.1517","volume":"22","author":"F Zhao","year":"2009","unstructured":"Zhao F, Liu Z-Q (2009) The protective effect of hydroxyl-substituted Schiff bases on the radical-induced oxidation of DNA. J Phys Org Chem 22:791\u2013798. https:\/\/doi.org\/10.1002\/poc.1517","journal-title":"J Phys Org Chem"},{"issue":"5\u20136","key":"2117_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1515\/mgmc-2018-0031","volume":"41","author":"J Liu","year":"2018","unstructured":"Liu J, Liu M, Wang S, Li Y, Liu M, Wang Y, Tian L, Liu X (2018) Syntheses and crystal structures of three bis(triorganotin) benzenedicarboxylates. Main Group Metal Chem 41(5\u20136):155\u2013160. https:\/\/doi.org\/10.1515\/mgmc-2018-0031","journal-title":"Main Group Metal Chem"},{"key":"2117_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jorganchem.2015.12.007","volume":"803","author":"Q Wang","year":"2016","unstructured":"Wang Q, Zhang J, Sun J (2016) A series of new tin compounds derived from 4-mercaptophenylacetic acid: synthesis and characterization. J Organomet Chem 803:128\u2013133. https:\/\/doi.org\/10.1016\/j.jorganchem.2015.12.007","journal-title":"J Organomet Chem"},{"key":"2117_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ica.2024.122093","volume":"568","author":"R Vinayak","year":"2024","unstructured":"Vinayak R, Basu D, Bhowmick A, Ghosh A, Nayek HP (2024) Imine-functionalized organotin(IV) carboxylates: syntheses, structures and antibacterial activities. Inorg Chim Acta 568:e122093. https:\/\/doi.org\/10.1016\/j.ica.2024.122093","journal-title":"Inorg Chim Acta"},{"key":"2117_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jorganchem.2020.121654","volume":"935","author":"X Du","year":"2021","unstructured":"Du X, Zhang R, Li Q, Cheng S, Li Y, Ru J, Ma C (2021) Organotin(IV) complexes derived from 1,4-naphthalenedicarboxylic acid: synthesis, structure, in vitro cytostatic activity. J Organometal Chem 935:e121654. https:\/\/doi.org\/10.1016\/j.jorganchem.2020.121654","journal-title":"J Organometal Chem"},{"key":"2117_CR43","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1039\/b617136b","volume":"9","author":"L Yang","year":"2007","unstructured":"Yang L, Powell DR, Houser RP (2007) Structural variation in copper(I) complexes with pyridylmethylamide ligands: structural analysis with a new four-coordinate geometry index, \u03c44. Dalton Trans 9:955\u2013964. https:\/\/doi.org\/10.1039\/b617136b","journal-title":"Dalton Trans"},{"key":"2117_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.poly.2015.01.035","volume":"90","author":"A Okuniewski","year":"2015","unstructured":"Okuniewski A, Rosiak D, Chojnacki J, Becker B (2015) Coordination polymers and molecular structures among complexes of mercury(II) halides with selected 1-benzoylthioureas. Polyhedron 90:47\u201357. https:\/\/doi.org\/10.1016\/j.poly.2015.01.035","journal-title":"Polyhedron"},{"key":"2117_CR45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/978-94-007-4771-5","volume-title":"Introduction to structural chemistry","author":"SS Batsanov","year":"2012","unstructured":"Batsanov SS, Batsanov AS (2012) Introduction to structural chemistry. Springer, Heidelberg, p 542. https:\/\/doi.org\/10.1007\/978-94-007-4771-5 (ISBN 978-94-007-4771-5 (eBook))"},{"issue":"9","key":"2117_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1023\/A:1011625728803","volume":"37","author":"SS Batsanov","year":"2001","unstructured":"Batsanov SS (2001) Van der Waals Radii of elements. Inorg Mater 37(9):871\u2013885. https:\/\/doi.org\/10.1023\/A:1011625728803","journal-title":"Inorg Mater"},{"key":"2117_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/hc.21356","volume":"28","author":"X Xiao","year":"2017","unstructured":"Xiao X, Sui C, Han L, Liu J, Feng B (2017) Self-assembly of triorganotin(IV) moiety with 1,2,4,5-benzenetetracarboxylic acid: syntheses, characterizations, and influence of solvent on the molecular structure (II). Heteroatom Chem 28:e21356. https:\/\/doi.org\/10.1002\/hc.21356","journal-title":"Heteroatom Chem"},{"key":"2117_CR48","doi-asserted-by":"publisher","first-page":"6880","DOI":"10.1039\/C3DT53469C","volume":"43","author":"DB Shpakovsky","year":"2014","unstructured":"Shpakovsky DB, Banti CN, Mukhatova EM, Gracheva YuA, Osipova VP, Berberova NT, Albov DV, Antonenko TA, Aslanov LA, Milaeva ER, Hadjikakou SK (2014) Synthesis, antiradical activity and in vitro cytotoxicity of novel organotin complexes based on 2,6-di-tert-butyl-4-mercaptophenol. Dalton Trans 43:6880\u20136890. https:\/\/doi.org\/10.1039\/C3DT53469C","journal-title":"Dalton Trans"},{"issue":"8","key":"2117_CR49","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1515\/pac-2019-1209","volume":"92","author":"ER Milaeva","year":"2020","unstructured":"Milaeva ER, Shpakovsky DB, Gracheva YA, Antonenko TA, Ksenofontova TD, Nikitin EA, Berseneva DA (2020) Novel selective anticancer agents based on Sn and Au complexes. Mini-review. Pure Appl Chem 92(8):1201\u20131216. https:\/\/doi.org\/10.1515\/pac-2019-1209","journal-title":"Pure Appl Chem"},{"issue":"3","key":"2117_CR50","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1134\/S1070328423700446","volume":"49","author":"IV Smolyaninov","year":"2023","unstructured":"Smolyaninov IV, Burmistrova DA, Pomortseva NP, Voronina YK, Poddel\u2019sky AI, Berberova NT, Eremenko IL (2023) Complexes R2Sn(IV)L with O, N, O\u2019-donor schiff bases: synthesis, structures, and redox properties. Russ J Coord Chem 49(3):124\u2013141. https:\/\/doi.org\/10.1134\/S1070328423700446","journal-title":"Russ J Coord Chem"},{"issue":"3","key":"2117_CR51","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms24032024","volume":"24","author":"TA Antonenko","year":"2023","unstructured":"Antonenko TA, Gracheva YA, Shpakovsky DB, Vorobyev MA, Mazur DM, Tafeenko VA, Oprunenko YF, Shevtsova EF, Shevtsov PN, Nazarov AA, Milaeva ER (2023) Biological activity of novel organotin compounds with a Schiff base containing an antioxidant fragment. Int J Mol Sci 24(3):2024. https:\/\/doi.org\/10.3390\/ijms24032024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2117_CR52","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.3390\/ijms24098319","volume":"24","author":"IV Smolyaninov","year":"2023","unstructured":"Smolyaninov IV, Poddel\u2019sky AI, Burmistrova DA, Voronina YK, Pomortseva NP, Polovinkina MA, Almyasheva NR, Zamkova MA, Berberova NT, Eremenko IL (2023) Synthesis and biological activity of organotin complexes with thio-Schiff bases bearing phenol fragments. Int J Mol Sci 24(9):8319. https:\/\/doi.org\/10.3390\/ijms24098319","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2117_CR53","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1134\/S1070328424600293","volume":"50","author":"DA Burmistrova","year":"2024","unstructured":"Burmistrova DA, Pomortseva NP, Pashaeva KD, Polovinkina MP, Al\u2019myasheva NR, Dolgushin FM, Tselukovskaya ED, Anan\u2019ev IV, Demidov OP, Poddel\u2019skii AI, Berberova NT, Eremenko IL, Smolyaninov IV (2024) Complexes R2Sn(IV)L with tridentate O, N, O\u2019-donor Schiff bases: photophysical properties and biological activity. Russ J Coord Chem 50(7):440\u2013457. https:\/\/doi.org\/10.1134\/S1070328424600293","journal-title":"Russ J Coord Chem"},{"key":"2117_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2024.105698","volume":"17","author":"S Rahim","year":"2024","unstructured":"Rahim S, Sadiq A, Javed A, Noor A, Muhammad N, Ibrahim M, Qayyum S, Ayub K, Fatima N, Sarfaraz S, Assad M, Kubicki M (2024) Synthesis, characterization, enzyme inhibition, antioxidant, anticancer and antimicrobial potential of organotin(IV) derivatives of 4-fluorophenoxyacetic acid. Arab J Chem 17:105698. https:\/\/doi.org\/10.1016\/j.arabjc.2024.105698","journal-title":"Arab J Chem"},{"key":"2117_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotochem.2023.114881","volume":"443","author":"MZ Kabir","year":"2023","unstructured":"Kabir MZ, Tayyab H, Erkmen C, Mohamad SB, Uslu B (2023) Spectroscopic, voltammetric and computational approaches shed light on the combination characteristics of an anticancer agent, bexarotene with human serum albumin. J Photochem Photobiol 443:114881. https:\/\/doi.org\/10.1016\/j.jphotochem.2023.114881","journal-title":"J Photochem Photobiol"},{"key":"2117_CR56","doi-asserted-by":"publisher","first-page":"202405000","DOI":"10.1002\/slct.202405000","volume":"10","author":"R Khan","year":"2025","unstructured":"Khan R, Dindar CK, Karayel A, Silah H, Kurnal\u0131 SZ, Haider A, Uslu B (2025) Evaluating the interaction between the antineoplastic drug bexarotene and double-stranded DNA using electrochemical. Spectrosc Mol Docking Stud 10:202405000. https:\/\/doi.org\/10.1002\/slct.202405000","journal-title":"Spectrosc Mol Docking Stud"},{"issue":"6","key":"2117_CR57","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/156652412800792598","volume":"12","author":"R Hanaf","year":"2012","unstructured":"Hanaf R, Anestopoulos I, Voulgaridou GP, Franco R, Georgakilas AG, Ziech D, Malamou-Mitsi V, Pappa A, Panayiotidis MI (2012) Oxidative stress based-biomarkers in oral carcinogenesis: how far have we gone? Curr Mol Med 12(6):698\u2013703. https:\/\/doi.org\/10.2174\/156652412800792598","journal-title":"Curr Mol Med"},{"key":"2117_CR58","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/aoc.360","volume":"16","author":"VD Petrosyan","year":"2002","unstructured":"Petrosyan VD, Milaeva ER, Gracheva YuA, Grigoriev EV, Tyurin VYu, Pimenov YuT, Berberova NT (2002) The promoting effect of organotin compounds upon peroxidation of oleic acid. Appl Organomet Chem 16:655\u2013659. https:\/\/doi.org\/10.1002\/aoc.360","journal-title":"Appl Organomet Chem"},{"issue":"2","key":"2117_CR59","doi-asserted-by":"publisher","first-page":"0436","DOI":"10.36922\/td.0436","volume":"2","author":"A Mahajan","year":"2023","unstructured":"Mahajan A, Singh L, Singh G, Dhawan RK, Kaur M, Malhi PK, Thakur K, Kaur L (2023) An evidence-based review on bexarotene. Tumor Discov 2(2):0436. https:\/\/doi.org\/10.36922\/td.0436","journal-title":"Tumor Discov"},{"key":"2117_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/aoc.2854","volume":"26","author":"IV Smolyaninov","year":"2012","unstructured":"Smolyaninov IV, Antonova NA, Poddel\u2019sky AI, Osipova VP, Berberova NT, Pimenov Y (2012) The influence of some triphenylantimony(V) catecholates and o-amidophenolates on lipid peroxidation in vitro. Appl Organometal Chem 26:277\u2013283. https:\/\/doi.org\/10.1002\/aoc.2854","journal-title":"Appl Organometal Chem"},{"key":"2117_CR61","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/aoc.3120","volume":"28","author":"IV Smolyaninov","year":"2014","unstructured":"Smolyaninov IV, Antonova NA, Poddel\u2019sky AI, Smolyaninova SA, Osipova VP, Luzhnova SA, Berberova NT, Pimenov YT (2014) The influence of triphenylantimony(V)catecholate and its spiroendoperoxide on lipid peroxidation. Appl Organometal Chem 28:274\u2013279. https:\/\/doi.org\/10.1002\/aoc.3120","journal-title":"Appl Organometal Chem"},{"issue":"16","key":"2117_CR62","doi-asserted-by":"publisher","first-page":"9011","DOI":"10.3390\/ijms25169011","volume":"25","author":"DA Burmistrova","year":"2024","unstructured":"Burmistrova DA, Pomortseva NP, Voronina YuK, Kiskin MA, Dolgushin FM, Berberova NT, Eremenko IL, Poddel\u2019sky AI, Smolyaninov IV (2024) Synthesis, structure, electrochemical properties, and antioxidant activity of organogermanium(IV) catecholate complexes. Int J Mol Sci 25(16):9011. https:\/\/doi.org\/10.3390\/ijms25169011","journal-title":"Int J Mol Sci"},{"key":"2117_CR63","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.bmcl.2017.12.033","volume":"28","author":"L Chen","year":"2018","unstructured":"Chen L, Long C, Nguyen J, Kumar D, Lee J (2018) Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer. Bioorg Med Chem Lett 28:420\u2013424. https:\/\/doi.org\/10.1016\/j.bmcl.2017.12.033","journal-title":"Bioorg Med Chem Lett"},{"key":"2117_CR64","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4236\/jct.2011.25096","volume":"2","author":"J Trappmann","year":"2011","unstructured":"Trappmann J, Hawk SN (2011) The effects of n-3 fatty acids and bexarotene on breast cancer cell progression. J Cancer Ther 2:710\u2013714. https:\/\/doi.org\/10.4236\/jct.2011.25096","journal-title":"J Cancer Ther"},{"issue":"9","key":"2117_CR65","first-page":"1657","volume":"67","author":"N Janakiram","year":"2007","unstructured":"Janakiram N, Steele V, Rao C (2007) Combined effects of raloxifene (SERM) and bexarotene (Rexinoid) on growth suppression of colon cancer cells. Cancer Res 67(9):1657","journal-title":"Cancer Res"},{"key":"2117_CR66","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1021\/acs.jmedchem.6b00812","volume":"59","author":"MC Heck","year":"2016","unstructured":"Heck MC, Wagner CE, Shahani PH, MacNeill M, Grozic A, Darwaiz T, Shimabuku M, Deans DG, Robinson NM, Salama SH, Ziller JW, Ma N, van der Vaart A, Marshall PA, Jurutka PW (2016) Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR)-selective agonists: analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (Bexarotene) and 6-(ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic acid (NEt-TMN). J Med Chem 59:8924\u20138940. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00812","journal-title":"J Med Chem"},{"key":"2117_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccr.2007.12.026","volume":"253","author":"SK Hadjikakou","year":"2009","unstructured":"Hadjikakou SK, Hadjiliadis N (2009) Antiproliferative and anti-tumor activity of organotin compounds. Coord Chem Rev 253:235\u2013249. https:\/\/doi.org\/10.1016\/j.ccr.2007.12.026","journal-title":"Coord Chem Rev"},{"key":"2117_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.657599","volume":"9","author":"SN Syed Annuar","year":"2021","unstructured":"Syed Annuar SN, Kamaludin NF, Awang N, Chan KM (2021) Cellular basis of organotin(IV) derivatives as anticancer metallodrugs: a review. Front Chem 9:657599. https:\/\/doi.org\/10.3389\/fchem.2021.657599","journal-title":"Front Chem"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-025-02117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00775-025-02117-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-025-02117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:04:06Z","timestamp":1754355846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00775-025-02117-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":68,"journal-issue":{"issue":"4-5","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00775-025-02117-w","relation":{},"ISSN":["1432-1327"],"issn-type":[{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}